ArticleBioMed research international2023

Evaluation of Serum Fructosamine as Diagnostic Marker of Postoperative Recurrence in the Patients with Breast Cancer.

Yuanqing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.